company background image
QIPT

Quipt Home Medical TSXV:QIPT Stock Report

Last Price

CA$6.09

Market Cap

CA$204.4m

7D

-1.3%

1Y

-23.4%

Updated

25 Jun, 2022

Data

Company Financials +
QIPT fundamental analysis
Snowflake Score
Valuation6/6
Future Growth5/6
Past Performance2/6
Financial Health4/6
Dividends0/6

QIPT Stock Overview

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States.

Quipt Home Medical Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Quipt Home Medical
Historical stock prices
Current Share PriceCA$6.09
52 Week HighCA$8.87
52 Week LowCA$5.14
Beta1.77
1 Month Change3.40%
3 Month Change13.62%
1 Year Change-23.40%
3 Year Change95.19%
5 Year Changen/a
Change since IPO38.41%

Recent News & Updates

Jun 08
When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Quipt Home Medical Corp. ( CVE:QIPT ), might not be a large cap stock, but it saw a significant share price rise of...

Shareholder Returns

QIPTCA HealthcareCA Market
7D-1.3%3.4%0.3%
1Y-23.4%-33.7%-4.1%

Return vs Industry: QIPT exceeded the Canadian Healthcare industry which returned -33.7% over the past year.

Return vs Market: QIPT underperformed the Canadian Market which returned -4.1% over the past year.

Price Volatility

Is QIPT's price volatile compared to industry and market?
QIPT volatility
QIPT Average Weekly Movement7.3%
Healthcare Industry Average Movement8.3%
Market Average Movement9.9%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market4.3%

Stable Share Price: QIPT is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: QIPT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993n/aGreg Crawfordhttps://quipthomemedical.com

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment.

Quipt Home Medical Fundamentals Summary

How do Quipt Home Medical's earnings and revenue compare to its market cap?
QIPT fundamental statistics
Market CapUS$158.22m
Earnings (TTM)US$7.86m
Revenue (TTM)US$118.43m

20.1x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
QIPT income statement (TTM)
RevenueUS$118.43m
Cost of RevenueUS$30.99m
Gross ProfitUS$87.44m
Other ExpensesUS$79.59m
EarningsUS$7.86m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.23
Gross Margin73.83%
Net Profit Margin6.63%
Debt/Equity Ratio24.0%

How did QIPT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is QIPT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QIPT?

Other financial metrics that can be useful for relative valuation.

QIPT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.4x
Enterprise Value/EBITDA13.3x
PEG Ratio0.5x

Price to Earnings Ratio vs Peers

How does QIPT's PE Ratio compare to its peers?

QIPT PE Ratio vs Peers
The above table shows the PE ratio for QIPT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average54.1x

Price-To-Earnings vs Peers: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (54.1x).


Price to Earnings Ratio vs Industry

How does QIPT's PE Ratio compare vs other companies in the Healthcare Industry?

Price-To-Earnings vs Industry: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the Canadian Healthcare industry average (36.6x)


Price to Earnings Ratio vs Fair Ratio

What is QIPT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QIPT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.1x
Fair PE Ratio30.7x

Price-To-Earnings vs Fair Ratio: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the estimated Fair Price-To-Earnings Ratio (30.7x).


Share Price vs Fair Value

What is the Fair Price of QIPT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: QIPT (CA$6.09) is trading below our estimate of fair value (CA$71.82)

Significantly Below Fair Value: QIPT is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: QIPT is good value based on its PEG Ratio (0.5x)


Discover undervalued companies

Future Growth

How is Quipt Home Medical forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


43.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: QIPT's forecast earnings growth (43.3% per year) is above the savings rate (1.6%).

Earnings vs Market: QIPT's earnings (43.3% per year) are forecast to grow faster than the Canadian market (8.3% per year).

High Growth Earnings: QIPT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: QIPT's revenue (21.8% per year) is forecast to grow faster than the Canadian market (7.3% per year).

High Growth Revenue: QIPT's revenue (21.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if QIPT's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Quipt Home Medical performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


27.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: QIPT has a large one-off gain of $9.3M impacting its March 31 2022 financial results.

Growing Profit Margin: QIPT became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: QIPT has become profitable over the past 5 years, growing earnings by 27.3% per year.

Accelerating Growth: QIPT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: QIPT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-68.2%).


Return on Equity

High ROE: QIPT's Return on Equity (12%) is considered low.


Discover strong past performing companies

Financial Health

How is Quipt Home Medical's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: QIPT's short term assets ($44.0M) exceed its short term liabilities ($28.5M).

Long Term Liabilities: QIPT's short term assets ($44.0M) exceed its long term liabilities ($16.3M).


Debt to Equity History and Analysis

Debt Level: QIPT has more cash than its total debt.

Reducing Debt: QIPT's debt to equity ratio has increased from 5.4% to 24% over the past 5 years.

Debt Coverage: QIPT's debt is well covered by operating cash flow (154%).

Interest Coverage: Insufficient data to determine if QIPT's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Dividend

What is Quipt Home Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate QIPT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate QIPT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if QIPT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if QIPT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as QIPT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.5yrs

Average management tenure


CEO

Greg Crawford

4.5yrs

Tenure

US$4,432,363

Compensation

Mr. Gregory J. Crawford also known as Greg, has been President, Chief Executive Officer and Chairman of Quipt Home Medical Corp. (formerly known as Protech Home Medical Corp.) since December 21, 2017 and s...


CEO Compensation Analysis

Compensation vs Market: Greg's total compensation ($USD4.43M) is above average for companies of similar size in the Canadian market ($USD751.41K).

Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: QIPT's management team is considered experienced (4.5 years average tenure).


Board Members

Experienced Board: QIPT's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.


Top Shareholders

Company Information

Quipt Home Medical Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: Quipt Home Medical Corp.
  • Ticker: QIPT
  • Exchange: TSXV
  • Founded: 1993
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: CA$204.372m
  • Shares outstanding: 33.56m
  • Website: https://quipthomemedical.com

Location

  • Quipt Home Medical Corp.
  • 1019 Town Drive
  • Wilder
  • Kentucky
  • 41076
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/25 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2021/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.